Noble Energy (NE - Get Report) was downgraded to underperform from neutral at Bank of America/Merrill Lynch. $5 price target. The valuation is less attractive, as the company has a lot of debt coming due in the next few quarters, analysts said.
Sysco (SYY - Get Report) was downgraded to neutral from outperform at Credit Suisse. $55 price target. The valuation is less attractive, as the stock has gained 50% in the past 18 months, Credit Suisse said.
Teva was downgraded to equal-weight from overweight at Morgan Stanley. $42 price target. Earnings estimates were also cut, given lower expected generics and Copaxone results, Morgan said.